D.J. Hoopes

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

The management of respiratory motion in radiation oncology report of AAPM Task Group 76a)

Surgical Treatment of Local Recurrence After Stereotactic Body Radiotherapy for Primary and Metastatic Lung Cancers

Guidelines on the radical management of patients with lung cancer

ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)

Stereotactic Body Radiation Therapy for Early-Stage Non–Small-Cell Lung Carcinoma: Four-Year Results of a Prospective Phase II Study

Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer

Stereotactic body radiation therapy for oligometastases

Drug development from marine natural products

Stereotactic body radiation therapy: a novel treatment modality

Immunogenic cell death in cancer and infectious disease

Type I interferons induced by radiation therapy mediate recruitment and effector function of CD8+ T cells

Stereotactic body radiation therapy for nonmetastatic lung cancer: An analysis of 75 patients treated over 5 years

British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)

Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease

Chemistry and clinical biology of the bryostatins

Lung cancer: current therapies and new targeted treatments

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Salvage Operation for Late Recurrence After Stereotactic Body Radiotherapy for Lung Cancer: Two Patients With No Viable Cancer Cells

Bryostatin-1: A Novel PKC Inhibitor in Clinical Development

Cancer and Radiation Therapy: Current Advances and Future Directions

The role of local therapy in the management of lung and liver oligometastases

Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review

Natural compounds for cancer treatment and prevention

Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT – the Nordic experience

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Salvage surgery after high-dose radiotherapy

Stereotactic body radiation therapy of early-stage non–small-cell lung carcinoma: Phase I study

European Organisation for Research and Treatment of Cancer Recommendations for Planning and Delivery of High-Dose, High-Precision Radiotherapy for Lung Cancer

Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases

Impact of Natural Products on Developing New Anti-Cancer Agents

Stereotactic Body Radiation Therapy: Scope of the Literature

Stereotactic body radiation therapy for early-stage non-small-cell lung cancer

Baseline Pulmonary Function as a Predictor for Survival and Decline in Pulmonary Function Over Time in Patients Undergoing Stereotactic Body Radiotherapy for the Treatment of Stage I Non–Small-Cell Lung Cancer

The inhibitory effects of bryostatin 1 administration on the growth of rabbit papillomas

FDG-PET and Stereotactic Body Radiotherapy (SBRT) for Stage I Non-small Cell Lung Cancer

FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer